SCHEMBL6204961

SCHEMBL6204961

CN(C)CC(=C=O)c1ccsc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
DAO P14920 1/20 0.41
HDAC1 Q13547 1/20 0.38
HPGD P15428 1/20 0.33
HSD11B1 P28845 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
C5AR1 P21730 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
GPR52 Q9Y2T5 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
ALOX12 P18054 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289811 0.74 EGFR (0.50) HPGDNPC1RAB9AALDH1A1MAPT
SCHEMBL5514907 0.74 CES2 (0.44) CES2CES1LCKFYNDAO
SCHEMBL5774143 0.71 HTT (0.40) HPGDALDH1A1MEN1LMNAKMT2A
SCHEMBL5185723 0.71 MAOA (0.41) CES2CES1HDAC1HPGDNPC1
SCHEMBL8804423 0.69 NPC1 (0.37) CES2CES1LCKFYNDAO
SCHEMBL6026523 0.69 KDM4E (0.43) ALDH1A1KDM4E
SCHEMBL290340 0.69 CES2 (0.46) CES2CES1HDAC1HPGDALDH1A1
SCHEMBL4777431 0.69 MAOA (0.45) CES2CES1DAOHDAC1HPGD
SCHEMBL5776042 0.69 NOS1 (0.42) ALDH1A1MEN1KMT2A
SCHEMBL8865574 0.69 CES2 (0.56) CES2CES1LCKFYNDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558607-A1 COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES Vertex Pharmaceuticals Incorporated (US) 2005-08-03 EP disclosed
WO-2004041813-A1 COMPOSITIONS USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 WO disclosed